Lidocaine improves survival rate in diabetic rats submitted to acute left coronary artery ligation

Archiv für Kreislaufforschung - Tập 85 - Trang 404-410 - 1990
S. Rousscau-Migneron1, G. Tancrède1, A. Nadeau1
1Unité de Recherche sur le Diabète Le Centre de Recherche du CHUL, Le Centre Hospitalier de l'Université Laval, Ste-Foy, Canada

Tóm tắt

This study was designed to evaluate whether the decreased early survival rate of diabetic rats submitted to acute experimental myocardial infarction can be improved by pretreatment with lidocaine. Male Wistar rats (±210g) were rendered diabetic with i.v. injection of streptozotocin (50 mg/kg), and only those presenting 1 week later a tail-blood glucose value between 250–400 mg/dl were retained in the protocol. Eleven weeks after induction of diabetes, a bolus of lidocaine (2mg/kg) was administered i.v. about 6 min prior to ligation of the left coronary artery under ether anesthesia in control (n=54) and diabetic (n=48) rats; similar studies were conducted in 53 control and 55 diabetic rats without lidocaine pretreatment. Adequate occlusion was confirmed by an elevation of plasma CK-MB levels 4h later or by a toluidine blue injection technique in rats which died earlier. Rats were followed over 48h and comparison in the survival rate in each group established with the Fisher's exact test. Early survival rate (measured after 20 min) was significantly decreased in diabetic rats (27% vs 45%; p=0.04). This was greatly improved by lidocaine pretreatment in diabetic (60% vs 27%; p=0.0013), but not in control animals (50% vs 45%; p=0.384). Furthermore, the beneficial effect of prophylactic lidocaine observed early after coronary ligation in diabetic rats was maintained throughout the period of observation (48h). These data suggest that the prophylactic use of lidocaine is able to reverse the increased incidence of sudden death following experimental myocardial infarction in chronically diabetic rats.

Tài liệu tham khảo

Allen JD, Brennan FJ, Wit AL (1978) Actions of lidocaine on transmembrane potentials of subendocardiol Purkinje fibers surviving in infarcted canine hearts. Circ Res 43:470–481 Anderson JL (1984) Current understanding of lidocaine as an antiarrhythmic agent: a review. Clin Ther 6:125–141 Bakth S, Arena J, Lee W, Torres R, Haider B Patel BC, Lyons MM, Regan TJ (1986) Arrhythmia susceptibility and myocardial composition in diabetes. Influence of physical conditioning. J Clin Invest 77:382–395 Beatch GN, McNeill JH (1988) Ventricular arrhythmias following coronary artery occlusion in the streptozotocin diabetic rat. Can J Physiol Pharmacol 66:312–317 Bergey JL, Nocella K, McCallum JD (1982) Acute coronary artery occlusion-reperfusion induced arrhythmias in rats, dogs and pigs; antiarrhythmic evaluation of quinidine, procainamide and lidocaine. Eur J Pharmacol 81:205–216 Bigger JT, Mandell WJ (1970) Effect of lidocaine on the electrophysiological properties of ventricular muscle and Purkinje fibers. J Clin Invest 49:63–77 Campbell RW (1984) Prophylactic antiarrhythmic therapy in acute myocardial infarction. Am J Cardiol 54:8E-10E Chobanian AV, Arquilla ER, Clarkson TB, Eder HA, Havard CF, Regan TJ, Williamson JR (1982) Cardiovascular complications. Diabetes 31. Suppl 1:54–64 Clark C, Foreman MI, Kane KA, McDonald FM, Parratt JR (1980) Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size. J Pharmacol Methods. 3:357–368 Curtis MJ, MacLeod BA, Walker MJA (1987) Models for the study of arrhythmias in myocardial ischaemia and infarction: the use of the rat. J Mol Cell Cardiol 19:399–419 Czyzk A, Krolewski AS, Szablowska S, Alot A, Kopczynski J (1980) Clinical course of myocardial infarction among diabetic patients. Diabetes Care 3:526–529 Desbuquois B, Aurbach GD (1971) Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radio-immunoassays. J Clin Endocrinol 33:732–728 Fein FS, Kornstein LB, Strobeck JE, Capasso JM, Sonnenblick EH (1980) Altered myocardial mechanics in diabetic rats. Circ Res 47:922–933 Fischer VW, Barner HB, Leskiw ML (1979) Capillary basal laminar thickness in diabetic human myocardium. Diabetes 28:713–719 Giachetti A (1978) The functional state of sympathetic nerves in spontaneously diabetic mice. Diabetes 27:969–974 Jarrett RJ, McCartney P, Keen H (1982) The Bedford survey: Ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia 22:79–84 Johnston KM, MacLeod BA, Walker MJA (1983) Responses to ligation of a coronary artery in conscious rats and the actions of antiarrhythmics. Can J Physiol Pharmacol 61:1340–1353 Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease. The Framingham study. JAMA 241:2035–2038 Kessler II (1971) Mortality experience of diabetic patients. A twenty-six year follow-up study. Am J Med 51:715–724 Kinnaird AAA, Man RYK (1986) The effect of lidocaine compared with verapamil on the enhanced ventricular rhythm in the infarcted canine heart. Can J Physiol Pharmacol 64:472–476 Krolewski AS, Czyzyk A, Janeczko D, Kopczynski J (1977) Mortality from cardiovascular diseases among diabetics, Diabetologia 13:345–350 Kupersmith J, Antman EM, Hoffman BF (1975) In vivo electrophysiological effects of lidocaine in canine acute myocardial infarction. Circ Res 36:84–91 Lancet (1979) Anti-dysrhythmic treatment in acute myocardial infarction. Editorial. Lancet I:193–194 Lepran I, Koltai M, Siegmund W, Szekeres L (1983) Coronary artery ligation, early arrhythmias, and determination of the ischemic area in conscious rats. J Pharmacol Methods 9:219–230 MacMahon S, Collins R, Peto R, Koster RW, Yusuf S (1988) Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. JAMA 260:1910–1916 Manufacturer's instructions Cardiotrac-CK Kit, Corning, Palo Alto, California Nadeau A, Tancrède G, Jobidon C, D'Amours C, Rousseau-Migneron S (1986) Increased mortality rate in diabetic rats submitted to acute experimental myocardial infarction. Cardiovasc Res 20:171–175 Nadeau A, Tancréde G, Rousseau-Migneron S (1987) Acute diabetes mellitus does not impair survival rate in rats submitted to left coronary artery ligation. Can J Cardiol 3:90–93 Nadeau A, Tancrède G, Jean C, Rousseau-Migneron S (1987) Decreased creatine kinase activity in the heart of streptozotocin-diabetic rats. Clin Invest Med 10, Suppl 4:B67 O'Sullivan JB, Mahan CM (1982) Mortality related to diabetes and blood glucose levels in a community study. Am J Epidemiol 116:678–684 Partamian JO, Bradley RF (1965) Acute myocardial infarction in 258 cases of diabetes: immediate mortality and five year survival N Engl J Med 27:455–461 Popovic V, Popovic P (1960) Permanent cannulation of aorta and vena cava in rats and ground squirrels. J Appl Physiol 15:727–728 Regan TG, Ettinger PO, Khan ML, Jesrani MU, Lyons MM, Oldewurtel HA, Weber M (1974) Altered myocardial function and metabolism in chronic diabetes mellitus without ischemia in dogs. Circ Res 35:222–237 Richterich R, Dauwalder H (1971) Zur Bestimmung der Plasmaglucosekonzentration mit der Hexokinase-Glucose-6-Phosphat-Dehydrogenase-Methode. Schweiz Med Wochenschr 101:615–618 Savabi F (1988) Mitochondrial creatine phosphokinase deficiency in diabetic rat heart. Biochem Biophys Res Commun 154:469–475 Selye H, Bajusz E, Grasso S, Mendell P (1960) Simple techniques for the surgical occlusion of coronary vessels in the rat. Angiology 11:398–407 Senges J, Brachmann J, Pelzer D, Hasslacher C, Weihe E, Kübler W (1980) Altered cardiac automaticity and conduction in experimental diabetes mellitus. J Mol Cell Cardiol 12:1341–1351 Shell WE, Kjekshus JK, Sobel BE (1971) Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity. J Clin Invest 50:2614–2625 Soler NG, Pentecost BL, Bennett MA, Fitzgerald MG, Lamb P, Malins JM (1974) Coronary care for myocardial infarction in diabetics. Lancet 1:475–477 Tahiliani AG, McNeill JH (1986) Diabetes induced abnormalities in the myocardium. Life Sci 38:959–974 Vigorito C, Betocchi S, Bonzani G, Guidice P, Miceli D, Piscione F, Condorelli M (1980) Severity of coronary artery disease in patients with diabetes mellitus. Angiographic study of 34 diabetic and 120 non-diabetic patients. Am Heart J 100:782–787 Weitzman S, Wagner GS, Heiss G, Haney TL, Slome C (1982) Myocardial infarction site and mortality in diabetes. Diabetes Care 5:31–35 Zammit Maempel JV (1978) Effect of diabetes on the course of acute myocardial infarction in Malta. Israel J Med Sci 14:424–431